The Clinical Impact of MDS Stem Cells in Patients Undergoing Allogeneic Transplant
Memorial Sloan-Kettering Cancer Center was awarded a $287,500 grant to support early career investigator Dr. Stephen Chung.
Dr. Chung will conduct this research with the support of his mentor Dr. Ross Levine to examine the effectiveness of bone marrow transplant (BMT), currently the only known cure for MDS. Their studies will provide new insights into how MDS stem cells resist eradication by BMT. And may lead to new diagnostic tests that can identify patients at the highest risk for relapse who may benefit from novel post-BMT therapies.
This grant was transferred with Dr. Chung to the University of Texas – Southwestern in 2018.
Learn more about University of Texas – Southwestern.